Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000519435 | SCV000618257 | likely benign | not provided | 2021-10-04 | criteria provided, single submitter | clinical testing | In-frame duplication of 1 amino acid in a repetitive region with no known function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001081641 | SCV001002063 | likely benign | Hereditary spastic paraplegia 49 | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001848912 | SCV002105911 | likely benign | Hereditary spastic paraplegia | 2019-09-01 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001081641 | SCV002088008 | benign | Hereditary spastic paraplegia 49 | 2019-09-25 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003900089 | SCV004718866 | likely benign | TECPR2-related disorder | 2022-04-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |